Precision BioSciences Inc (DTIL) stock
DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.10+0.05 (+0.71%)
Close on Nov 18, 2026Market cap $195.97MP/E –Yield –
Precision BioSciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Precision BioSciences's profit margin for the twelve months ending Jun 30, 2026 was -117.0%. For fiscal 2025 it was -133.4%, against 10.4% the year before. The highest annual figure on record is 10.4% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -133.4% | −143.9 |
| FY2024 | Dec 31, 2024 | 10.4% | +136.3 |
| FY2023 | Dec 31, 2023 | -125.8% | +319.0 |
| FY2022 | Dec 31, 2022 | -444.8% | −418.3 |
| FY2021 | Dec 31, 2021 | -26.5% | +422.4 |
| FY2020 | Dec 31, 2020 | -448.9% | −31.2 |
| FY2019 | Dec 31, 2019 | -417.6% | +5.4 |
| FY2018 | Dec 31, 2018 | -423.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -170.2% | +70743.6 |
| Q4 FY2025 | Dec 31, 2025 | 58.9% | +2840.2 |
| Q3 FY2025 | Sep 30, 2025 | -167476.9% | −164625.4 |
| Q2 FY2025 | Jun 30, 2025 | -130666.7% | −130732.3 |
| Q1 FY2025 | Mar 31, 2025 | -70913.8% | −70962.6 |
| Q4 FY2024 | Dec 31, 2024 | -2781.3% | −2549.9 |
| Q3 FY2024 | Sep 30, 2024 | -2851.6% | −2790.0 |
| Q2 FY2024 | Jun 30, 2024 | 65.6% | +125.7 |
| Q1 FY2024 | Mar 31, 2024 | 48.8% | +334.3 |
| Q4 FY2023 | Dec 31, 2023 | -231.4% | +37.4 |
| Q3 FY2023 | Sep 30, 2023 | -61.6% | +263.6 |
| Q2 FY2023 | Jun 30, 2023 | -60.1% | +752.3 |
| Q1 FY2023 | Mar 31, 2023 | -285.4% | +563.8 |
| Q4 FY2022 | Dec 31, 2022 | -268.8% | +82.8 |
| Q3 FY2022 | Sep 30, 2022 | -325.2% | −278.3 |
| Q2 FY2022 | Jun 30, 2022 | -812.4% | −843.9 |
| Q1 FY2022 | Mar 31, 2022 | -849.2% | −734.9 |
| Q4 FY2021 | Dec 31, 2021 | -351.6% | −86.5 |
| Q3 FY2021 | Sep 30, 2021 | -46.9% | +306.4 |
| Q2 FY2021 | Jun 30, 2021 | 31.5% | +3065.0 |
| Q1 FY2021 | Mar 31, 2021 | -114.3% | +269.2 |
| Q4 FY2020 | Dec 31, 2020 | -265.1% | +55.6 |
| Q3 FY2020 | Sep 30, 2020 | -353.3% | +73.0 |
| Q2 FY2020 | Jun 30, 2020 | -3033.5% | −2672.8 |
| Q1 FY2020 | Mar 31, 2020 | -383.5% | +198.4 |
| Q4 FY2019 | Dec 31, 2019 | -320.7% | −8.1 |
| Q3 FY2019 | Sep 30, 2019 | -426.4% | −42.4 |
| Q2 FY2019 | Jun 30, 2019 | -360.7% | +270.4 |
| Q1 FY2019 | Mar 31, 2019 | -581.9% | +7.9 |
| Q4 FY2018 | Dec 31, 2018 | -312.6% | – |
| Q3 FY2018 | Sep 30, 2018 | -383.9% | – |
| Q2 FY2018 | Jun 30, 2018 | -631.1% | – |
| Q1 FY2018 | Mar 31, 2018 | -589.8% | – |
See a number that looks wrong?